TLR4-mediated Neuroinflammation in SLE through phosphorylation of MyD88/IRAK signaling pathway

The citation data is computed by the following citation measuring services:

1. Murphy K, Innate Immunity: The First Lines of Defense. Janeway's Immunobiology, Garland Science, Taylor & Francis Group, Abingdon, UK, 8th edition, 2012.
2. Aran AA, Putterman C. Treatment of lupus nephritis: facing the era of immunotherapy. Panminerva Med 2008; 50:235-245.
3. Nimmerjahn A, Kirchhoff F, Helmchen F. Neuroscience: resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005;308:1314-1318. https://doi.org/10.1126/science.1110647
4. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. Journal of Clinical Pathology 2003;56(7):481-490. https://doi.org/10.1136/jcp.56.7.481
5. Pisetsky DS. Systemic lupus erythematosus. A. Epidemiology, pathology and pathogenesis. In: Klippel JH, ed. Primer on the rheumatic diseases, 11th ed. Georgia, USA: Arthritis Foundation, 1997:246-51.
6. Yun HR, Koh HK, Kim SS, et al. FcgammaRIIa/IIIa polymorphism and its association with clinical manifestations in Korean lupus patients. Lupus 2001;10:466-72. https://doi.org/10.1191/096120301678416015
7. Kim F, Pham M, Luttrell I, et al. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circulation Research 2007;100(11):1589-1596. https://doi.org/10.1161/CIRCRESAHA.106.142851
8. Gangloff M. Different dimerisation mode for TLR4 upon endosomal acidification? Trends Biochem. Sci 2012; 37:92-98. https://doi.org/10.1016/j.tibs.2011.11.003
9. Shi H, Kokoeva MV, Inouye K, et al. TLR-4 links innate immunity and fatty acid-induced insulin resistance. Journal of Clinical Investigation 2006;116(11):3015-3025. https://doi.org/10.1172/JCI28898
10. de Batista PR, Palacios R, Martín A, et al. TLR-4 upregulation by angiotensin II contributes to hypertension and vascular dysfunction through reactive oxygen species production. PLoS ONE 2014;9(8): e104020. https://doi.org/10.1371/journal.pone.0104020  
11. Wolf G, Bohlender J, Bondeva T, et al. Angiotensin II upregulates TLR-4 on mesangial cells. J Am Soc Nephrol 2006;17:1585-1593. https://doi.org/10.1681/ASN.2005070699
12. Sollinger D, Eißler R, Lorenz R, et al. Damage-associated molecular pattern activated Toll-like receptor 4 signalling modulates blood pressure in l-NAME-induced hypertension. Cardiovascular Research 2014;101(3):464-472. https://doi.org/10.1093/cvr/cvt265
13. Suganami T, Tanimoto-Koyama K, Nishida J, et al. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 2007;27:84-91. https://doi.org/10.1161/01.ATV.0000251608.09329.9a
14. Bomfim GF, Dos Santos RA, Oliveira MA, et al. Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats. Clin Sci (Lond) 2012;122:535-543. https://doi.org/10.1042/CS20110523
15. Asehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-κB. J Immunol 2004;172: 2522-2529. https://doi.org/10.4049/jimmunol.172.4.2522
16. Pi Y, Zhang LL, Li BH, et al. Inhibition of reactive oxygen species generation attenuates TLR4-mediated proinflammatory and proliferative phenotype of vascular smooth muscle cells. Lab Invest 2003;93: 880-887. https://doi.org/10.1038/labinvest.2013.79
17. Zhang Z, Li W, Sun D, et al. TLR-4 signaling in dysfunction of cardiac microvascular endothelial cells under hypoxia/reoxygenation. Inflamm Res 2011;60: 37-45.  https://doi.org/10.1007/s00011-010-0232-2
18. Liang CF, Liu JT, Wang Y, Xu A, Vanhoutte PM. TLR-4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH Oxidase isoforms 1 and 4. Arterioscler Thromb Vasc Biol 2013; 33:777-784. https://doi.org/10.1161/ATVBAHA.112.301087
19. Marketou ME, Kontaraki JE, Zacharis EA, et al. TLR2 and TLR-4 gene expression in peripheral monocytes in nondiabetic hypertensive patients: the effect of intensive blood pressure-lowering. J Clin Hypertens (Greenwich) 2012;14: 330-335. https://doi.org/10.1111/j.1751-7176.2012.00620.x
20. Sollinger D, Eiβler R, Lorenz S, et al. Damage-associated molecular pattern activated Toll-like receptor 4 signalling modulates blood pressure in L-NAME-induced hypertension. Cardiovasc Res 2014;101:464-472. https://doi.org/10.1093/cvr/cvt265
21. Bomfim GF, Dos Santos RA, Oliveira MA, et al. TLR-4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats. Clin Sci 2012;122:535-543. https://doi.org/10.1042/CS20110523
22. Eiβler R, Schmaderer C, Rusai K, et al. Hypertension augments cardiac TLR-4 expression and activity. Hypertens Res 2001;34:551-558. https://doi.org/10.1038/hr.2010.270
23. Pineda A, Verdin-Terán SL, Camacho A, Moreno-Fierros L. Expression of Toll-like Receptor TLR-2, TLR-3, TLR-4 and TLR-9 is increased in placentas from patients with preeclampsia. Arch Med Res 2011;42:382-391. https://doi.org/10.1016/j.arcmed.2011.08.003
24. Kim YM, Romero R, Oh SY, et al. TLR-4: a potential link between "danger signals," the innate immune system, and preeclampsia? Am J Obstet Gynecol 2005;193:921-927. https://doi.org/10.1016/j.ajog.2005.07.076
25. Devaraj S, Dasu MR, Rockwood J, et al. Increased Toll-like Receptor (TLR) 2 and TLR-4 expression in monocytes from patients with Type 1 Diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 2008;93:578-583. https://doi.org/10.1210/jc.2007-2185

For any technique error please contact us 

Who Can Become a Reviewer?
Any expert in the article's research field can become a reviewer with American Journal of Biomedicine. Editors might ask you to look at a specific aspect of an article,...

Find out more